参考文献/References:
[1].中国心血管健康与疾病报告编写组,胡盛寿. 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志,2023,38(6):583-612.
[2].Lang RM,Badano LP,Mor-Avi V,et al. Recommendations for cardiac chamber quantification by echocardiography in adults:an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. J Am Soc Echocardiogr,2015,28(1):1-39.e14.
[3].Stankovic I,Putnikovic B,Cvjetan R,et al. Visual assessment vs. strain imaging for the detection of critical stenosis of the left anterior descending coronary artery in patients without a history of myocardial infarction[J]. Eur Heart J Cardiovasc Imaging,2015,16(4):402-409.
[4].Velasco O,Beckett MQ,James AW,et al. Real-time three-dimensional echocardiography:characterization of cardiac anatomy and function-current clinical applications and literature review update[J]. Biores Open Access,2017,6(1):15-18.
[5].Kawel-Boehm N,Kronmal R,Eng J,et al. Left ventricular mass at MRI and long-term risk of cardiovascular events :the Multi-Ethnic Study of Atherosclerosis (MESA)[J]. Radiology,2019,293(1):107-114.
[6].Hadeed K,Hascoet S,Dulac Y,et al. Tethering of tricuspid valve resulting from aberrant tendinous cords mimic ebstein’s anomaly,three-dimensional echocardiography approach[J]. Echocardiography,2014,31(4):E136-E137.
[7].Cai Q,Ahmad M. Left ventricular dyssynchrony by three-dimensional echocardiography:current understanding and potential future clinical applications[J]. Echocardiography,2015,32(8):1299-1306.
[8].Marsan NA,Bleeker GB,Ypenburg C,et al. Real-time three-dimensional echocardiography permits quantification of left ventricular mechanical dyssynchrony and predicts acute response to cardiac resynchronization therapy[J]. J Cardiovasc Electrophysiol,2008,19(4):392-399.
[9].Parikh K,Choy-Shan A,Ghesani M,et al. Multimodality imaging of myocardial viability[J]. Curr Cardiol Rep,2021,23(1):5.
[10].Palermi S,Sperlongano S,Mandoli GE,et al. Exercise stress echocardiography in athletes:applications,methodology,and challenges[J]. J Clin Med,2023,12(24):7678.
[11].陈颖,杨盟盟,王岳恒. 影像学评估心肌存活性的研究进展[J]. 中国心血管病研究,2023,21(8):763-768.
[12].Lin Y,Guan X,Ren K,et al. Low-dose dobutamine stress myocardial contrast echocardiography for the evaluation of myocardial microcirculation and prediction of overall cardiac function recovery[J]. Exp Ther Med,2020,20(2):1315-1320.
[13].Pellikka PA,Arruda-Olson A,Chaudhry FA,et al. Guidelines for performance,interpretation,and application of stress echocardiography in ischemic heart disease:from the American Society of Echocardiography[J]. J Am Soc Echocardiogr,2020,33(1):1-41.
[14].Taqueti VR. Coronary flow reserve:a versatile tool for interrogating pathophysiology,and a reliable marker of cardiovascular outcomes and mortality[J]. Eur Heart J,2022,43(16):1594-1596.
[15].Kiviniemi TO,Toikka JO,Koskenvuo JW,et al. Vasodilation of epicardial coronary artery can be measured with transthoracic echocardiography[J]. Ultrasound Med Biol,2007,33(3):362-370.
[16].Iliceto S,Marangelli V,Memmola C,et al. Transesophageal Doppler echocardiography evaluation of coronary blood flow velocity in baseline conditions and during dipyridamole-induced coronary vasodilation[J]. Circulation,1991,83(1):61-69.
[17].Wada T,Hirata K,Shiono Y,et al. Coronary flow velocity reserve in three major coronary arteries by transthoracic echocardiography for the functional assessment of coronary artery disease:a comparison with fractional flow reserve[J]. Eur Heart J Cardiovasc Imaging,2014,15(4):399-408.
[18].Meimoun P,Benali T,Elmkies F,et al. Prognostic value of transthoracic coronary flow reserve in medically treated patients with proximal left anterior descending artery stenosis of intermediate severity[J]. Eur J Echocardiogr,2009,10(1):127-132.
[19].Dijkmans PA,Senior R,Becher H,et al. Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate,rapid,and safe assessment of myocardial perfusion:the evidence so far[J]. J Am Coll Cardiol,2006,48(11):2168-2177.
[20].Wei K,Ragosta M,Thorpe J,et al. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography[J]. Circulation,2001,103(21):2560-2565.
[21].Lyu WY,Qin CY,Wang XT,et al. The application of myocardial contrast echocardiography in assessing microcirculation perfusion in patients with acute myocardial infarction after PCI[J]. BMC Cardiovasc Disord,2022,22(1):233.
[22].Hickman M,Chelliah R,Burden L,et al. Resting myocardial blood flow,coronary flow reserve and contractile reserve in hibernating myocardium:implications for using resting myocardial contrast echocardiography vs dobutamine echocardiography for the detection of hibernating myocardium[J]. Eur J Echocardiogr,2010,11:756-762.
[23].Bierig SM,Mikolajczak P,Herrmann SC,et al. Comparison of myocardial contrast echocardiography derived myocardial perfusion reserve with invasive determination of coronary flow reserve[J]. Eur J Echocardiogr,2009,10(2):250-255.
[24].Ashraf,T,Khan,MN,Afaque,SM,et al. Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention[J]. Int J Cardiol,2019,294:27-31.
[25].Porter TR,Mulvagh SL,Abdelmoneim SS,et al. Clinical applications of ultrasonic enhancing agents in echocardiography:2018 American Society of Echocardiography Guidelines Update[J]. J Am Soc Echocardiogr,2018,31(3):241-274.
[26].中国超声心动图学会,中华医学会超声医学分会浅表组织和血管学组,中国医药教育学会超声医学专业委员会. 慢性冠状动脉综合征负荷超声心动图检查临床实践指南(2023版)[J]. 中华超声影像学杂志,2023,32(11):921-945.
[27].汤乔颖,邓又斌. 超声斑点追踪技术评价左心室局部功能的进展[J]. 中华超声影像学杂志,2012,21(2):171-174.
[28].刘家佳,张璐,张艳,等. 斑点追踪分层应变技术评估急性冠状动脉综合征合并糖尿病患者左室心肌分层应变及其与甘油三酯葡萄糖指数的相关性[J]. 临床超声医学杂志,2023,25(6):423-429.
[29].Ancedy Y,Ederhy S,Jean ML,et al. Does layer-specific strain using speckle tracking echocardiography improve the assessment of left ventricular myocardial deformation? A review[J]. Arch Cardiovasc Dis,2020,113(11):721-735.
[30].Ran H,Yao Y,Wan L,et al. Characterizing stenosis severity of coronary heart disease by myocardial work measurement in patients with preserved ejection fraction[J]. Quant Imaging Med Surg,2023,13(8):5022-5033.
[31].Tagliamonte E,Sperlongano S,Montuori C,et al. Coronary microvascular dysfunction affects left ventricular global longitudinal strain response to dipyridamole stress echocardiography:a pilot study[J]. Heart Vessels,2023,38(4):470-477.
[32].Ran H,Zhang PY,Zhang YX,et al. Assessment of left ventricular myocardial viability by 3-dimensional speckle-tracking echocardiography in patients with myocardial infarction [J]. J Ultrasound Med,2016,35(8):1631-1638.
[33].Ran H,Zhang PY,Fang LL,et al. Clinic value of two-dimensional speckle tracking combined with adenosine stress echocardiography for assessment of myocardial viability [J]. Echocardiography,2012,29(6):688-694.
[34].Tsch?pe C,Senni M. Usefulness and clinical relevance of left ventricular global longitudinal systolic strain in patients with heart failure with preserved ejection fraction[J]. Heart Fail Rev,2020,25(1):67-73.
[35].Onishi T,Saha SK,Delgado-Montero A,et al. Global longitudinal strain and global circumferential strain by speckle-tracking echocardiography and feature-tracking cardiac magnetic resonance imaging:comparison with left ventricular ejection fraction[J]. J Am Soc Echocardiogr,2015,28(5):587-96.
[36].Roemer S,Jaglan A,Santos D,et al. The utility of myocardial work in clinical practice[J]. J Am Soc Echocardiogr,2021,34(8):807-818.
[37].Mutluer FO,Bowen DJ,van Grootel RWJ,et al. Left ventricular strain values using 3D speckle-tracking echocardiography in healthy adults aged 20 to 72?years[J]. Int J Cardiovasc Imaging. 2021 Apr;37(4):1189-1201.
[38].Russell K,Eriksen M,Aaberge L,et al. A novel clinical method for quantification of regional left ventricular pressure-strain loop area:a non-invasive index of myocardial work[J]. Eur Heart J,2012,33(6):724-733.
[39].Manganaro,R,Marchetta,S,Dulgheru,R,et al. Echocardiographic reference ranges for normal non-invasive myocardial work indices:results from the EACVI NORRE study[J]. Eur Heart J Cardiovasc Imaging,2019,20(5):582-590.
[40].王岩,鲁洪涛,尹璐瑶,等. 超声心肌做功技术对左前降支狭窄患者左心室收缩功能的诊断价值[J]. 中国医学影像学杂志,2023,31(4):349-355.
[41].van der Bijl P,Vo NM,Kostyukevich MV,et al. Prognostic implications of global,left ventricular myocardial work efficiency before cardiac resynchronization therapy[J]. Eur Heart J Cardiovasc Imaging,2019,20(12):1388-1394.
[42].Butcher SC,Fortuni F,Montero-Cabezas JM,et al. Right ventricular myocardial work:proof-of-concept for non-invasive assessment of right ventricular function[J]. Eur Heart J Cardiovasc Imaging,2021,22(2):142-152.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(9):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(9):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(9):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(9):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(9):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(9):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(9):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(9):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(9):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]黄晓凤 熊峰.超声心动图技术在优化心脏再同步化治疗效果中的应用[J].心血管病学进展,2019,(7):1043.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.020]
HUANG XiaofengXIONG Feng.Application of Echocardiography in Optimizing Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2019,(9):1043.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.020]
[11]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(9):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]